Moreover, studies have shown a low prevalence of BRCA1/2 mutations in CCA (≤4%) 21, 22, while another study revealed that the frequency of BRCA1 and BRCA2 mutations was 17 and 0% in extrahepatic CCA cases, respectively 23. This evidence concerns the gene BRCA1 and cholangiocarcinoma.